- Report
- June 2023
- 182 Pages
Global
From €3576EUR$3,600USD£2,974GBP
- Report
- May 2022
- 84 Pages
Middle East, Africa
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2022
- 82 Pages
Asia Pacific
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2022
- 84 Pages
Europe
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2022
- 72 Pages
North America
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2022
- 197 Pages
Global
From €3576EUR$3,600USD£2,974GBP
- Report
- August 2022
- 96 Pages
Global
From €4962EUR$4,995USD£4,126GBP
- Report
- May 2024
- 80 Pages
Argentina
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Brazil
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
China
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
France
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Germany
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Ireland
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Japan
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Poland
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Russia
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- May 2024
- 80 Pages
South Korea
From €1490EUR$1,500USD£1,239GBP
From €1490EUR$1,500USD£1,239GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more